Sofwave Medical Ltd (SOFW) - Total Assets
Based on the latest financial reports, Sofwave Medical Ltd (SOFW) holds total assets worth ILA58.30 Million ILA (≈ $156.30K USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore SOFW debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Sofwave Medical Ltd - Total Assets Trend (2018–2025)
This chart illustrates how Sofwave Medical Ltd's total assets have evolved over time, based on quarterly financial data. See Sofwave Medical Ltd book value and equity for net asset value and shareholders' equity analysis.
Sofwave Medical Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Sofwave Medical Ltd's total assets of ILA58.30 Million consist of 91.9% current assets and 8.1% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 62.3% |
| Accounts Receivable | ILA9.18 Million | 16.5% |
| Inventory | ILA5.12 Million | 9.2% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA0.00 | 0.0% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how Sofwave Medical Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Sofwave Medical Ltd (SOFW) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sofwave Medical Ltd's current assets represent 91.9% of total assets in 2025, a decrease from 94.8% in 2018.
- Cash Position: Cash and equivalents constituted 62.3% of total assets in 2025, up from 22.3% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is accounts receivable at 16.5% of total assets.
Sofwave Medical Ltd Competitors by Total Assets
Key competitors of Sofwave Medical Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Insulet Corporation
NASDAQ:PODD
|
USA | $2.99 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
|
China | CN¥3.54 Billion |
|
Ningbo David Medical Device Co Ltd
SHE:300314
|
China | CN¥1.45 Billion |
|
Ilex Medical
TA:ILX
|
Israel | ILA947.26 Million |
|
EBR Systems Inc
AU:EBR
|
Australia | AU$97.29 Million |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO
|
India | Rs8.57 Billion |
Sofwave Medical Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.43 | 2.25 | 10.83 |
| Quick Ratio | 2.18 | 1.88 | 10.80 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA31.31 Million | ILA21.04 Million | ILA49.53 Million |
Sofwave Medical Ltd - Advanced Valuation Insights
This section examines the relationship between Sofwave Medical Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 17.99 |
| Latest Market Cap to Assets Ratio | 7.46 |
| Asset Growth Rate (YoY) | 29.6% |
| Total Assets | ILA55.78 Million |
| Market Capitalization | $415.96 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Sofwave Medical Ltd's assets at a significant premium (7.46x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Sofwave Medical Ltd's assets grew by 29.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Sofwave Medical Ltd (2018–2025)
The table below shows the annual total assets of Sofwave Medical Ltd from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ILA55.78 Million ≈ $149.55K |
+29.63% |
| 2024-12-31 | ILA43.03 Million ≈ $115.36K |
-1.16% |
| 2023-12-31 | ILA43.54 Million ≈ $116.72K |
-5.51% |
| 2022-12-31 | ILA46.08 Million ≈ $123.53K |
-24.18% |
| 2021-12-31 | ILA60.77 Million ≈ $162.92K |
+1160.77% |
| 2020-12-31 | ILA4.82 Million ≈ $12.92K |
-22.63% |
| 2019-12-31 | ILA6.23 Million ≈ $16.70K |
+950.59% |
| 2018-12-31 | ILA593.00K ≈ $1.59K |
-- |
About Sofwave Medical Ltd
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and … Read more